MedTrace Logo

Does Immunotherapy Have a Role in the Management of Endometriosis?

NCT03464799 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2018-08-14

No results posted yet for this study

Summary

Pathological specimens of 40 women that had been operated for endometriosis will be included in this study. These tissues will be stained with a marker named as PDL-1 in pathological examination. "programmed cell death (PD-1)" is expressed on T cells. The immunotherapies in which antibodies against these PD-1 and its ligands (PDL-1) have been used are accepted as very effective in the treatment of many cancers. If these ligands can be shown in the endometriosis, it will be an important step for the treatment of endometriosis.

Conditions

  • Endometriosis

Interventions

OTHER

immunohistochemical staining

immunohistochemical staining

Sponsors & Collaborators

  • Kanuni Sultan Suleyman Training and Research Hospital

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-30
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03464799 on ClinicalTrials.gov